MedPath

Comparability of Bispectral Index and NeuroSENSE in Aged Patients

Withdrawn
Conditions
Sleep
Registration Number
NCT02015741
Lead Sponsor
Hopital Foch
Brief Summary

The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA).

Use of such devices is discussed in aged patients. The purpose of this study is to compare Bispectral Index and NeuroSENSE during awake periods and during natural sleep.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • patients older than 74 years
Exclusion Criteria
  • pace-maker

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with a high concordance between pairs of Bispectral Index and NeuroSENSE indices1 year

Statistical analysis of concordance between pairs of Bispectral Index and NeuroSENSE indices (high concordance when \> 0.60%)

Secondary Outcome Measures
NameTimeMethod
Percentage of patients with a high concordance between pairs of Bispectral Index and NeuroSENSE indices during periods of natural sleep1 year

Statistical analysis of concordance between pairs of Bispectral Index and NeuroSENSE indices measured during periods of natural sleep (high concordance when \> 0.60%)

Trial Locations

Locations (2)

Hopital Stell

🇫🇷

Rueil, Hauts de Seine, France

Hopital Foch

🇫🇷

Suresnes, Hauts de Seine, France

Hopital Stell
🇫🇷Rueil, Hauts de Seine, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.